Notice of Effectiveness (effect)
May 19 2022 - 6:05AM
Edgar (US Regulatory)
UNITED STATES
|
---|
SECURITIES AND EXCHANGE COMMISSION
|
---|
Washington, D.C. 20549
|
---|
NOTICE OF EFFECTIVENESS |
---|
|
Effective Date: | May 18,
2022 |
---|
Form: | S-3 |
---|
CIK: | 0001404644 |
---|
Company Name: | Neoleukin Therapeutics, Inc. |
---|
File Number: | 333-264803 |
---|
Neoleukin Therapeutics (NASDAQ:NLTX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Neoleukin Therapeutics (NASDAQ:NLTX)
Historical Stock Chart
From Sep 2023 to Sep 2024